Recalculating the Route: Repositioning Antimicrobial Peptides for Cancer Treatment
Chemistry & Biodiversity · 2024
DOI: 10.1002/cbdv.202301840 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemistry & Biodiversity, 2024. Verfasst von Isadora de Almeida Gomes und 11 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Rua Coronel Nunes de Melo 1000, Fortaleza, CE,…. Hauptthemen laut MEDLINE: Anti-Infective Agents, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Brazilian Agencies CNPq, CAPES, Federal University of Ceará.
Abstract (Originalsprache)
Resistance to antimicrobial drugs has been considered a public health problem. Likewise, the increasing resistance of cancer cells to drugs currently used in therapy has also become a problem. Therefore, the research and development of synthetic peptides bring a new perspective on the emergence of new drugs for treating this resistance since bioinformatics provides a means to optimize these molecules and save time and costs in research. Peptides have several mechanisms of action, such as forming pores on the cell membrane and inhibiting protein synthesis. Some studies report the use of antimicrobial peptides with the potential for action against cancer cells, suggesting a repositioning of antimicrobial peptides to fight back cancer resistance. There is an alteration in the microenvironment, making its net charge negative for the survival and growth of cancer cells. The changes in glycoproteins favor the membrane to have a more negative charge, favoring the interaction between the cells and the peptide, thus making possible the repositioning of these antimicrobial peptides against cancer. Here, we will discuss the mechanism of action, targets and effects of peptides, comparison between microbial and cancer cells, and proteomic changes caused by the interaction of peptides and cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Rua Coronel Nunes de Melo 1000, Fortaleza, CE, 60430-275, Brazil.
- Department of Biochemistry and Molecular Biology, Federal University of Ceará, Fortaleza, 60020-181, CE, Brazil.
- Laboratory of Biophysics and Nanosystems, Physics Department, Federal University of Maranhão, São Luís, 65020070, Brazil.
- Department of Pathology and Legal Medicine, Federal University of Ceará, Fortaleza, Ceará, 60020-181, Brazil.
Förderung
- Brazilian Agencies CNPq
- CAPES
- Federal University of Ceará
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
de Almeida Gomes, I., da Lima, A. B., da Silva Brito, D. M., Almeida Lima, A., de Oliveira, F. L., Espino Zelaya, E. A., Magalhães Rebello Alencar, L., Castelo Branco de Souza Collares Maia, D., Amaral de Moraes, M. E., Pantoja Mesquita, F., Noronha Souza, P. F., & Montenegro, R. C. (2024). Recalculating the Route: Repositioning Antimicrobial Peptides for Cancer Treatment. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202301840
Vancouver
de Almeida Gomes I, da Lima AB, da Silva Brito DM, Almeida Lima A, de Oliveira FL, Espino Zelaya EA, et al. Recalculating the Route: Repositioning Antimicrobial Peptides for Cancer Treatment. Chemistry & Biodiversity. 2024. doi:10.1002/cbdv.202301840
BibTeX
@article{deAlmeidaGomes2024,
author = {de Almeida Gomes, Isadora and da Lima, Ana Beatriz and da Silva Brito, Daiane Maria and Almeida Lima, Arlene and de Oliveira, Francisco Laio and Espino Zelaya, Elmer Adilson and Magalhães Rebello Alencar, Luciana and Castelo Branco de Souza Collares Maia, Débora and Amaral de Moraes, Maria Elisabete and Pantoja Mesquita, Felipe and Noronha Souza, Pedro Filho and Montenegro, Raquel C},
title = {Recalculating the Route: Repositioning Antimicrobial Peptides for Cancer Treatment},
journal = {Chemistry & Biodiversity},
year = {2024},
doi = {10.1002/cbdv.202301840}
}
EUVIMED